Program

Friday, August 1, 2008  Saturday, August 2, 2008  POSTERS

Friday, August 1, 2008

7:30 am

Registration

8.00-8.30 am

Introduction
B.Vellas, P.Garry

8:30-10:00 am

Symposium I: Physical Exercise and Cognitive Functions

• Physical Exercise and Cognitive Decline in Animal Models, Carl W. Cotman, PhD
• Physical Activity and Cognitive Function in Humans , Patricia C. Heyn, PhD
• Effect of Fish Oil Supplementation on Cognitive Performance in Older Subjects: A Randomized, Double-Blind, Placebo Controlled Trial, Ondine van de Rest

*Physical Activity and Enhanced Fitness Improve Cognitive Function in Older People without Known Cognitive Impairment, a Cochrane Systematic Review. M. Angevaren, G. Aufdemkampe, H.J.J. Verhaar, A. Aleman, L. Vanhees (the Netherlands)

10:00-10:30 am

Refreshment Break and Poster Session

10:30-12:00 pm

Symposium II: Nutrition and Cognitive Decline

• A Systematic Review on Nutrition and Dementia, Peter J. Whitehouse, MD, PhD
• Beyond Magic Bullets: An Evidence-Based Nutrition Program for Persons with Alzheimer’s and MCI, Nancy Emerson Lombardo, PhD
• Health Promotion Program and Nutrition in Alzheimer Disease: The NutriActive Study, Antoni Salvà, MD
• Metabolism Disorders, Vascular Risk Factors and Cognitive Decline in Hispanic Elderly L. Jaime Fitten, MD

12:00-1:00 pm

Lunch and Poster Session

1:00-3:00 pm

Symposium III: Sarcopenia – How to Define It? Co-chairs: Tamara B. Harris, MD, MS and Zhao Chen, PhD, Panel Members: Marjolein Visser, PhD; Lynn M. Marshall, ScD and Scott B. Going,

• Symposium Overview, Tamara B. Harris, MD, MS
• Status and Challenges for Sarcopenia Definition, Scott B. Going, PhD
• NHANES Data on Sarcopenia, Tamara B. Harris, MD, MS
• Sarcopenia in Older U.S. Men – Results from the MrOS Cohort Study , Lynn M. Marshall, ScD
• Sarcopenia in U.S. Older Women – An Analysis with the WHI Cohort, Zhao Chen, PhD
• Sarcopenia in the European Population, Marjolein Visser, PhD
• A Comparison of the Health ABC Results with Other Cohorts, Tamara B. Harris, MD, MS
• How to Define Sarcopenia? Panel Discussion with Meeting Participants
• Conclusion, Zhao Chen, PhD

3:00-4:00 pm

Symposium IV: Frailty, Sarcopenia and Cognitive Decline

• Epidemiology of Sarcopenia, Wm. Cameron Chumlea, PhD
• Frailty and Cognitive Functions, Denis A. Evans, MD
• Physical Activity and Alzheimer’s Disease in a Population Study. N. Scarmeas, Y. Stern, N. Schupf, J.A. Luchsinger (USA)

4:00-4:20 pm

Refreshment Break and Poster Session

4:20-6:20 pm

Roundtable on Methodological Issues for Clinical Trials in Sarcopenia

• Introduction, Bruno Vellas, MD, PhD
• Clinical Trials for Sarcopenia: Review and Recommendations, William J. Evans, PhD and Luigi Ferrucci, MD, PhD
• Clinically Relevant Outcomes for Sarcopenia Trials, Roger A. Fielding, PhD
• How to Assess Sarcopenia in Clinical Trials, Stephanie A. Studensk, MD, MPH
• Therapeutic Potential Targets for Sarcopenia Clinical Trials, John E. Morley, MB, BCh
• Target Population for Clinical Trials, Marco Pahor, MD

*Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men: The HORMA Trial, F.R. Sattler, C. Castaneda-Sceppa, E.F. Binder, E.T. Schroeder, Y. Wang, S. Bhasin, M. Kawakubo, Y. Stewart, C.s Hahn, P. Colletti, R. Roubenoff, K.E. Yarasheski, S.P. Azen (USA)

 Download the full program  (28Kb)